Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
28 Cards in this Set
- Front
- Back
M phase specific
|
-vinca alkaloids
-taxanes |
|
G0 phase specific
|
-carmustine, lomustine
|
|
G1 phase specific
|
-asparaginase
|
|
S phase specific
|
-methotrexate
-cytarabine -fluorouracil -fludarabine -hydroxyurea |
|
G2 phase specific
|
-bleomycin
-etoposide, tenoposide |
|
fluorouracil
|
fluorinated pyrimidine metabolized to nucleotide fDUMP -> binds to thymidylate synthase (primary mech w/ continous infusion)
-triphosphate nucelotide metabolite incorporates into RNA as false metabolite (primary mech w/ intermittent bolus dosing) |
|
capecitabine
|
oral prodrug of 5-FU w/ tumor selectivity
|
|
cytarabine
|
penetrates cells via CMP -> phosphorylated to active triphosphate form (ara-CTP) -> inhibits DNA poly and incorporates itself into DNA
|
|
gemcitabine
|
inhibits DNA poly and ribonucleotide reductase
|
|
fludarabine monophosphate
|
fluorinated purine dephosphorylated in plasma -> activated within cell to triphosphate form (F-ara-ATP) -> inhibits DNA poly and transcription, blocks B and T cell function too
|
|
methotrexate
|
inhibits dihydrofolate reductase -> prevents DNA synthesis
|
|
pemetrexed
|
inhibits atleast 4 enzymes involved in folate metabolism and DNA synthesis
a)TS b)DHFR c)GARFT d)AICARFT |
|
vinca alkaloids
|
mitotic inhibitors or "spindle poisons"
-bind to tubulin inhibiting formation of mitotic spindle -> cells arrest in M phase |
|
taxanes
|
bind to tubulin and interfere with microtubule disassembly by inducing tubulin polymerization -> form stable but nonfunctional microtubules
|
|
topoisomerase inhibitors
|
forms complexes with topo I or II and DNA to inhibit strand rejoining after breakage (CCS=S or early G2)
|
|
anthracyclines (doxorubicin, daunorubicin, idarubicin)
|
-intercalation
-inhibition of topo II -free radical formation |
|
anthracyclines (mitoxantrone)
|
-intercalation
-less free radical formation (less cardiotoxicity) |
|
alkylating agents
|
form covalent bonds to result in cross-linking between DNA strands or between bases in same DNA strand ->inhibits DNA replication
|
|
platinums (cisplatin)
|
forms interstrand cross-linking of DNA-> prevent bases normally paired together from lining up
|
|
trastuzamab
|
HER2
|
|
rituximab
|
CD20 on B lymphocytes
|
|
ibrotumomab tiuxetan
|
anti-CD20 attached to radioactive yttrium (Y90)
|
|
tositumomab
|
anti-CD20 attached to radioactive iodine (I131)
|
|
gemtuzumab
|
anti-CD33
|
|
alemtuzumab
|
CD52 on T and B lymphocytes
|
|
cetuximab
|
EGFR
|
|
bevacizumab
|
VEGF preventing angiogenesis
|
|
tyrosine kinase inhibitors
|
"SIDES"
sorafenib, imatinib, desatinib, erlotinib, sunitinib |